EPZ004777 is a potential therapeutic molecule for NPM1-mut AML cells, and, in this study, the effects of EPZ004777 on OCI-AML2 and OCI-AML3 cell lines were examined. This evidence concerns the gene RUNX2 and acute myeloid leukemia.